M Doffoël

587 total citations
50 papers, 439 citations indexed

About

M Doffoël is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, M Doffoël has authored 50 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 25 papers in Hepatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in M Doffoël's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). M Doffoël is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). M Doffoël collaborates with scholars based in France, Belgium and South Africa. M Doffoël's co-authors include Patrick Marcellin, Jean‐Pierre Zarski, V. Canva, Vincent Leroy, C. Trépo, Karl Barange, Didier Samuel, Nathalie Ganne‐Carrié, Paul Calès and Armand Abergel and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Hepatology.

In The Last Decade

M Doffoël

46 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Doffoël France 12 312 284 61 55 28 50 439
Jun Niu China 9 134 0.4× 285 1.0× 83 1.4× 76 1.4× 23 0.8× 24 451
Μargarita Papatheodoridi Greece 14 356 1.1× 484 1.7× 38 0.6× 36 0.7× 17 0.6× 34 555
B.E. Annicchiarico Italy 11 372 1.2× 313 1.1× 26 0.4× 59 1.1× 38 1.4× 29 524
Po‐Heng Chuang Taiwan 13 289 0.9× 301 1.1× 23 0.4× 29 0.5× 18 0.6× 33 433
Thông Dao France 10 273 0.9× 238 0.8× 57 0.9× 151 2.7× 17 0.6× 27 448
Masatsugu Ohara Japan 12 305 1.0× 278 1.0× 23 0.4× 49 0.9× 37 1.3× 43 525
Jeong Eun Song South Korea 9 187 0.6× 216 0.8× 16 0.3× 56 1.0× 28 1.0× 27 348
Matthias Loehr Germany 7 282 0.9× 174 0.6× 21 0.3× 189 3.4× 65 2.3× 10 402
Xuefeng Ma China 13 76 0.2× 213 0.8× 49 0.8× 49 0.9× 24 0.9× 21 490

Countries citing papers authored by M Doffoël

Since Specialization
Citations

This map shows the geographic impact of M Doffoël's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Doffoël with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Doffoël more than expected).

Fields of papers citing papers by M Doffoël

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Doffoël. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Doffoël. The network helps show where M Doffoël may publish in the future.

Co-authorship network of co-authors of M Doffoël

This figure shows the co-authorship network connecting the top 25 collaborators of M Doffoël. A scholar is included among the top collaborators of M Doffoël based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Doffoël. M Doffoël is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saviano, Antonio, François Habersetzer, Joachim Lupberger, et al.. (2022). Safety and Antiviral Activity of EGFR Inhibition by Erlotinib in Chronic Hepatitis C Patients: A Phase Ib Randomized Controlled Trial. Clinical and Translational Gastroenterology. 13(6). e00492–e00492. 8 indexed citations
2.
Doffoël, M, et al.. (2019). Impact of Direct-acting Antivirals on Hepatitis C Cascade of Care among People who Inject Drugs. Journal of Antivirals & Antiretrovirals. 11(1). 1–5.
3.
Salvetat, Nicolas, Siem van der Laan, Bérengère Vire, et al.. (2019). RNA editing blood biomarkers for predicting mood alterations in HCV patients. Journal of NeuroVirology. 25(6). 825–836. 10 indexed citations
4.
Merle, Philippe, Philippe Camus, Armand Abergel, et al.. (2017). Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma. ESMO Open. 2(4). e000238–e000238. 36 indexed citations
5.
Doffoël, M, et al.. (2009). Screening and treatment of hepatitis C in drug users through a network of medical microstructures in Alsace, France, 2006-2007.. 400–404.
6.
Andrès, Emmanuel, Mustapha Mecili, Khalid Serraj, Laure Fédérici, & M Doffoël. (2007). Les atteintes digestives du syndrome de Gougerot-Sjögren primaire*. 13(2). 107–110. 1 indexed citations
7.
Doffoël, M, et al.. (2006). Traitement palliatif du carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique. 30(6-7). 887–890. 1 indexed citations
8.
Zarski, Jean‐Pierre, Patrick Marcellin, Vincent Leroy, et al.. (2006). Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases. Journal of Hepatology. 45(3). 355–360. 83 indexed citations
9.
Doffoël, M. (1999). Cirrhose alcoolique : anatomie pathologique, diagnostic, complications et leur physiopathologie, traitement. La Revue du praticien. 49(3). 320–326. 1 indexed citations
10.
Dhumeaux, Daniel, M Doffoël, & J P Galmiche. (1997). Conférence de consensus Paris, 16-17 janvier 1997 Hépatite C dépistage et traitement. Virologie. 1(2). 1 indexed citations
11.
Doffoël, M, et al.. (1993). [Liver transplantation in alcoholic cirrhosis].. PubMed. 43(9). 1124–8. 1 indexed citations
12.
Doffoël, M, et al.. (1989). Une cause rare de syndrome inflammatoire isolé:la maladie de whipple. La Revue de Médecine Interne. 10(1). 57–58. 3 indexed citations
13.
Doffoël, M, et al.. (1989). Results of orthotopic liver transplantation (OLT) in alcoholic cirrhosis. Journal of Hepatology. 9. S27–S27. 2 indexed citations
14.
Doffoël, M, et al.. (1988). [Hepatitis secondary to current non-steroidal anti-inflammatory agents].. PubMed. 55(12). 983–8. 6 indexed citations
15.
Vetter, D, et al.. (1988). [Study of insulin resistance in cirrhosis by the hyperinsulin euglycemia clamp].. PubMed. 12(5). 473–7. 1 indexed citations
16.
Doffoël, M, et al.. (1986). Effect of Intravenous and Intragastric Fat Infusion on Intestinal Brush Border Enzyme Activities in Rats. European Surgical Research. 18(2). 96–106. 19 indexed citations
17.
Doffoël, M, et al.. (1984). [Importance of disorders of primary hemostasis in the occurrence of upper digestive hemorrhage in cirrhosis].. PubMed. 20(4). 177–82. 1 indexed citations
18.
Chabrier, G, et al.. (1983). [Apoproteins A1 and B as markers of the severity of cirrhosis].. PubMed. 12(12). 739–42. 1 indexed citations
19.
Doffoël, M, et al.. (1981). Variations du glucagon, de l'insuline, du peptide-C et des acides aminés plasmatiques lors de l'épreuve d'hyperammoniémie provoquée par voie intro-veineuse chez le cirrhotique.. Gastroentérologie Clinique et Biologique. 5(12). 1 indexed citations
20.
Doffoël, M, et al.. (1980). [Relationship between portal hypertension, ascites, gastro-esophageal varices, and gastrointestinal bleeding in patients with alcoholic cirrhosis (author's transl)].. PubMed. 4(5). 376–82. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026